ICER to Review Most Significant Drug Price Hikes

June 20, 2020

The Institute for Clinical and Economic Review (ICER) is set to review whether the most significant drug price increases are evidence-based.

ICER on Friday released an updated protocol for the annual assessment.

An open input period on the drugs tapped for review began Friday, June 19, and will remain open until July 17.

To read the full press release, click here.

Click here to read the updated protocol.

Share This Story!